Center for Scientific Review; Notice of Closed Meetings, 13754 [2025-05062]
Download as PDF
<![CDATA[
13754
Federal Register / Vol. 90, No. 57 / Wednesday, March 26, 2025 / Notices
Agenda: To review and evaluate grant
applications.
Meeting Format: Virtual Meeting.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Erica L. Brown, Ph.D.,
Director, Division of Extramural Activities,
National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24C, Bethesda,
MD 20892, 301–594–4499, erica.brown@
nih.gov.
Members of the public are welcome to
provide written comments by emailing
NIGMS_DEA_Mailbox@nigms.nih.gov at least
3 days in advance of the meeting. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/about/council/Pages/
default, where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: March 21, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05152 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSK9W7S144PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Medical Imaging Investigations.
Date: May 1–2, 2025.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:57 Mar 25, 2025
Jkt 265001
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Carlos Jose Perez-Torres,
Scientific Review Officer, The Center for
Scientific Review, The National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–0451, carlos.perez-torres@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodegeneration.
Date: May 1, 2025.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kathryn Partlow, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D,
Bethesda, MD 20892, (301) 594–2138,
partlowkc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Radiation and Biology.
Date: May 5, 2025.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jennifer Ann Sanders,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–3553, jennifer.sanders@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
CounterACT cooperative agreements for
therapeutic development and basic research
on chemical threats affecting the nervous
system.
Date: May 7, 2025.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jonathan K. Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190,
MSC 7850, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Dated: March 20, 2025.
Sterlyn H. Gibson,
Program Specialist, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05062 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel: Cancer
Biology AREA/REAP Review, April 8,
2025, 11:00 a.m. to April 8, 2025, 3:00
p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
March 19, 2025, 90 FR 12742, FR Doc.
2025–04582.
This meeting is being amended to
change the start time from 11:00 a.m. to
12:00 p.m. on April 8, 2025. The
meeting is closed to the public.
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05075 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; DEM RC2 Review.
Date: April 30, 2025.
Time: 1:00 p.m. to 2:30 p.m.
E:\FR\FM\26MRN1.SGM
26MRN1
]]>Agencies
[Federal Register Volume 90, Number 57 (Wednesday, March 26, 2025)]
[Notices]
[Page 13754]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05062]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Medical Imaging Investigations.
Date: May 1-2, 2025.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Carlos Jose Perez-Torres, Scientific Review
Officer, The Center for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-0451,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurodegeneration.
Date: May 1, 2025.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kathryn Partlow, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D, Bethesda, MD 20892, (301)
594-2138, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Radiation and Biology.
Date: May 5, 2025.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jennifer Ann Sanders, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-3553,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: CounterACT cooperative agreements for therapeutic
development and basic research on chemical threats affecting the
nervous system.
Date: May 7, 2025.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jonathan K. Ivins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190, MSC 7850, Bethesda, MD
20892, (301) 594-1245, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 20, 2025.
Sterlyn H. Gibson,
Program Specialist, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-05062 Filed 3-25-25; 8:45 am]
BILLING CODE 4140-01-P
